New search | Conferencedetail
mail
Print view
 
 

Gene Therapy for Neurological Disorders

Evvnt Promotion / evvnt
-
06.12.2021 - 09.12.2021  The Colonnade Hotel, 120 Huntington Avenue, 02116 Boston, Massachusetts, USA
Time: 8:30 am - 5:30 pm
 
Conference themes
Returning to Boston this December, the 3rd Gene Therapy for Neurological Disorders meeting will welcome discovery, preclinical, translational and clinical industry scientists to share, learn and network for the shared goal of successfully and safely delivering gene therapies to the CNS.
Professional congress organizer (PCO)
Hanson Wade
Notes
Brochure: https://go.evvnt.com/853497-0?pid=4832

Speakers: Alan Foster, Chief Scientific Officer, Otonomy, Inc., Alexandra Watt, Lead Research Analyst, Beacon Targeted Therapies and more
 

Enquiries and Registration:

https://go.evvnt.com/853497-1?pid=4832
Ms. Ellie Saunders
 
Categories
Clinical Research, General Medicine
Languages
English
Congress fees
Full Access Pass - Physical - Standard Rate: USD 3593.00, Conference + Workshop Day OR Post Event Delivery Day - Physical - Standard Rate: USD 2846.00, Conference Only - Physical - Standard Rate: USD 2099.00
Organizer contact info
83 Great Titchfield Street
W1W 6RH London
United Kingdom
 
"Going International promotes access to education and training for all regardless of social, geographic and national borders."

AGEM - Arbeitsgemeinschaft Ethnologie und MedizinOÖ Gebietskrankenkasse, Referat für Wissenschaftskooperation Österreichische Gesellschaft für Public HealthSwiss Tropical and Public Health InstituteEuropean Health Forum GasteinAnästhesie in Entwicklungsländern e. V.newTreeÄrztekammer für Wien